Physician profile
Keith Alfieri
NPI 1922260512
$37,156.68
in general payments reported to CMS, 2019-2025
7 companies · $72.24 in 2025
The $72.24 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24K · 2021: $12K · 2022: $1,337 · 2023: $55.15 · 2024: $43.97 · 2025: $72.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $18,778.37 | 2020-2023 | Arthroplasty Implants Anatomic Total Shoulder Eclipse |
| Smith+Nephew, INC. | $8,224.12 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Firstpass, Healicoil |
| Djo, LLC | $5,000.00 | 2020-2021 | |
| Impactortho, INC. | $4,800.00 | 2021-2022 | |
| Stryker Corporation | $196.01 | 2021-2025 | Tornier Perform Reversed Augmented Glenoid, Tornier Perform Anatomic Augmented Glenoid, Simpliciti |
| Boston Scientific Corporation | $137.39 | 2022 | |
| Depuy Synthes Sales INC. | $20.79 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Alfieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.